Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP968965.RAR0hmXeDcU79gsb-CzSMqBjjiQ2vSSOfYDCxERgDWPMM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP968965.RAR0hmXeDcU79gsb-CzSMqBjjiQ2vSSOfYDCxERgDWPMM130_assertion type Assertion NP968965.RAR0hmXeDcU79gsb-CzSMqBjjiQ2vSSOfYDCxERgDWPMM130_head.
- NP968965.RAR0hmXeDcU79gsb-CzSMqBjjiQ2vSSOfYDCxERgDWPMM130_assertion wasGeneratedBy ECO_0000203 NP968965.RAR0hmXeDcU79gsb-CzSMqBjjiQ2vSSOfYDCxERgDWPMM130_provenance.
- NP968965.RAR0hmXeDcU79gsb-CzSMqBjjiQ2vSSOfYDCxERgDWPMM130_assertion wasDerivedFrom befree-2016 NP968965.RAR0hmXeDcU79gsb-CzSMqBjjiQ2vSSOfYDCxERgDWPMM130_provenance.
- NP968965.RAR0hmXeDcU79gsb-CzSMqBjjiQ2vSSOfYDCxERgDWPMM130_assertion SIO_000772 22430491 NP968965.RAR0hmXeDcU79gsb-CzSMqBjjiQ2vSSOfYDCxERgDWPMM130_provenance.
- NP968965.RAR0hmXeDcU79gsb-CzSMqBjjiQ2vSSOfYDCxERgDWPMM130_assertion evidence source_evidence_literature NP968965.RAR0hmXeDcU79gsb-CzSMqBjjiQ2vSSOfYDCxERgDWPMM130_provenance.
- NP968965.RAR0hmXeDcU79gsb-CzSMqBjjiQ2vSSOfYDCxERgDWPMM130_assertion description "[Estrogen, progesterone, and HER2 receptor-negative triple-negative breast cancers encompass the most clinically challenging subtype for which targeted therapeutics are lacking.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP968965.RAR0hmXeDcU79gsb-CzSMqBjjiQ2vSSOfYDCxERgDWPMM130_provenance.